"instituto oncologico"

During the past decade, Instituto Oncologico conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Oncologico" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator and "Wyeth is now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Oncologico" are "Cancer of the Prostate" (1 trials), "Castration-Resistant Prostate Cancer" (1 trials), "Chronic Myeloid Leukemia" (1 trials), "Head and Neck Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Instituto Oncologico" in a lesser frequency.

Most popular intervention types in "Instituto Oncologico" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Enzalutamide" (2 trials), "Bevacizumab [Avastin]" (1 trials), "Bosutinib" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Oncologico" are 3 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Instituto Oncologico". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Instituto Oncologico, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Oncologico, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".